Mood Stabilizer Valproate Promotes ERK Pathway-Dependent Cortical Neuronal Growth and Neurogenesis

Manic-depressive illness has been conceptualized as a neurochemical illness. However, brain imaging and postmortem studies reveal gray-matter reductions, as well as neuronal and glial atrophy and loss in discrete brain regions of manic-depressive patients. The roles of such cerebral morphological deficits in the neuropathophysiology and therapeutic mechanisms of manic-depressive illness are unknown. Valproate (2-propylpentanoate) is a commonly used mood stabilizer. The ERK (extracellular signal-regulated kinase) pathway is used by neurotrophic factors to regulate neurogenesis, neurite outgrowth, and neuronal survival. We found that chronic treatment of rats with valproate increased levels of activated phospho-ERK44/42 in neurons of the anterior cingulate, a region in which we found valproate-induced increases in expression of an ERK pathway-regulated gene, bcl-2. Valproate time and concentration dependently increased activated phospho-ERK44/42 and phospho-RSK1 (ribosomal S6 kinase 1) levels in cultured cortical cells. These increases were attenuated by Raf and MEK (mitogen-activated protein kinase/ERK kinase) inhibitors. Although valproate affects the functions of GSK-3 (glycogen synthase kinase-3) and histone deacetylase (HDAC), its effects on the ERK pathway were not fully mimicked by selective inhibitors of GSK-3 or HDAC. Similar to neurotrophic factors, valproate enhanced ERK pathway-dependent cortical neuronal growth. Valproate also promoted neural stem cell proliferation-maturation (neurogenesis), demonstrated by bromodeoxyuridine (BrdU) incorporation and double staining of BrdU with nestin, Tuj1, or the neuronal nuclei marker NeuN (neuronal-specific nuclear protein). Chronic treatment with valproate enhanced neurogenesis in the dentate gyrus of the hippocampus. Together, these data demonstrate that valproate activates the ERK pathway and induces ERK pathway-mediated neurotrophic actions. This cascade of events provides a potential mechanism whereby mood stabilizers alleviate cerebral morphometric deficits associated with manic-depressive illness.

[1]  P. Rakic,et al.  Cell Proliferation Without Neurogenesis in Adult Primate Neocortex , 2001, Science.

[2]  M. Berridge.  The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling. , 1989, JAMA.

[3]  J. Baraban,et al.  Identification of p42 Mitogen‐Activated Protein Kinase as a Tyrosine Kinase Substrate Activated by Maximal Electroconvulsive Shock in Hippocampus , 1993, Journal of neurochemistry.

[4]  Eric J. Nestler,et al.  Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus , 2000, The Journal of Neuroscience.

[5]  R. Duman,et al.  Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors , 2003, The Journal of Neuroscience.

[6]  J. Siuciak,et al.  Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures , 1999, Neuroscience.

[7]  V. Asghari,et al.  Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. , 1998, Brain research. Molecular brain research.

[8]  G. Moore,et al.  Lithium-induced increase in human brain grey matter , 2000, The Lancet.

[9]  R. Duman,et al.  Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  H. Sackeim,et al.  Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. , 1994, The American journal of psychiatry.

[11]  Husseini K. Manji,et al.  The Wnt Signaling Pathway in Bipolar Disorder , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[12]  Johan Bengzon,et al.  Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment , 2002, The European journal of neuroscience.

[13]  S. Apfel.  Is the therapeutic application of neurotrophic factors dead? , 2002, Annals of neurology.

[14]  M. Berridge.  Inositol Trisphosphate, Calcium, Lithium, and Cell Signaling , 1989 .

[15]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[16]  Johan Bengzon,et al.  Increased neurogenesis in a model of electroconvulsive therapy , 2000, Biological Psychiatry.

[17]  J. Gutkind,et al.  G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.

[18]  F. Goodwin.  Manic-Depressive Illness , 1990 .

[19]  H. Manji,et al.  The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation , 2003, The Journal of Neuroscience.

[20]  J. Coyle,et al.  Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments , 2003, Neuron.

[21]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[22]  W. McIntyre Burnham,et al.  Neurogenesis in the Dentate Gyrus of the Rat Following Electroconvulsive Shock Seizures , 2000, Experimental Neurology.

[23]  M. O’Connor,et al.  Long-Term Maintenance ECT: A Retrospective Review of Efficacy and Cognitive Outcome , 2003, The journal of ECT.

[24]  J. Calabrese,et al.  Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania , 1994 .

[25]  R. McKay,et al.  Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus , 2001, The Journal of comparative neurology.

[26]  S. Hsu,et al.  Protein A, avidin, and biotin in immunohistochemistry. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  H. Son,et al.  Differential effects of corticosterone and dexamethasone on hippocampal neurogenesis in vitro. , 2004, Biochemical and biophysical research communications.

[28]  Paul J. Harrison,et al.  The neuropathology of primary mood disorder. , 2002, Brain : a journal of neurology.

[29]  C. Hanstock,et al.  RETRACTED: Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain , 2003, European Neuropsychopharmacology.

[30]  John R. Geddes,et al.  Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis , 2003, The Lancet.

[31]  P. Muglia,et al.  The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. , 2002, American journal of human genetics.

[32]  H. Manji,et al.  Increase in AP-1 Transcription Factor DNA Binding Activity by Valproic Acid , 1997, Neuropsychopharmacology.

[33]  C. Bowden,et al.  Incorporation of [3H]valproic acid into lipids in GT1-7 neurons. , 1998, Biochemical pharmacology.

[34]  D. Chuang,et al.  Lithium Increases Transcription Factor Binding to AP‐1 and Cyclic AMP‐Responsive Element in Cultured Neurons and Rat Brain , 1997, Journal of neurochemistry.

[35]  Christina A. Wilson,et al.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. , 2003, Nature.

[36]  C. Gross,et al.  Adult-generated hippocampal and neocortical neurons in macaques have a transient existence , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Contreras,et al.  Region‐Specific Targets of p42/p44MAPK Signaling in Rat Brain , 1998, Journal of neurochemistry.

[38]  R. McKay,et al.  Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus , 1992, Neuron.

[39]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[40]  K. Anderson,et al.  BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons. , 1996, The European journal of neuroscience.

[41]  U. Kang,et al.  Activation and Tyrosine Phosphorylation of 44‐kDa Mitogen‐Activated Protein Kinase (MAPK) Induced by Electroconvulsive Shock in Rat Hippocampus , 1994, Journal of neurochemistry.

[42]  D. Chuang,et al.  Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition , 2003, FEBS letters.

[43]  R. Jope,et al.  Mood stabilizers, glycogen synthase kinase-3beta and cell survival. , 2002, Molecular psychiatry.

[44]  H. Manji,et al.  Lithium stimulates gene expression through the AP-1 transcription factor pathway. , 1998, Brain research. Molecular brain research.

[45]  A. Abdel‐Latif.  Cross Talk Between Cyclic Nucleotides and Polyphosphoinositide Hydrolysis, Protein Kinases, and Contraction in Smooth Muscle 1 , 2001, Experimental biology and medicine.

[46]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[47]  H. Manji,et al.  The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS , 1999, Journal of neurochemistry.

[48]  S. Gabriel,et al.  Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus , 2002, Molecular Psychiatry.

[49]  G. Edwards.  Textbook of psychopharmacology , 1975, Nature.

[50]  H. Gendelman,et al.  Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis , 2003, The Journal of Neuroscience.

[51]  C. M. Davenport,et al.  Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. , 1999, Science.

[52]  R. Jope,et al.  CREB DNA binding activity is inhibited by glycogen synthase kinase‐3β and facilitated by lithium , 2001, Journal of neurochemistry.

[53]  H. Chap,et al.  Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway. , 2002, Biochimica et biophysica acta.

[54]  G. Agam,et al.  Human 1-D-myo-Inositol-3-phosphate Synthase Is Functional in Yeast* , 2004, Journal of Biological Chemistry.

[55]  C. Hanstock,et al.  Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain , 2000, Brain Research.

[56]  Xin-Min Li,et al.  Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats , 2003, Brain Research.

[57]  F. Miller,et al.  Endogenously Produced Neurotrophins Regulate Survival and Differentiation of Cortical Progenitors via Distinct Signaling Pathways , 2003, The Journal of Neuroscience.

[58]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[59]  C. Vinson,et al.  An Essential Role for a MEK-C/EBP Pathway during Growth Factor-Regulated Cortical Neurogenesis , 2002, Neuron.

[60]  M. Guenther,et al.  Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.

[61]  M. Mattson,et al.  Evidence that brain‐derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice , 2002, Journal of neurochemistry.

[62]  J. Sweatt,et al.  Molecular Neurobiology of Human Cognition , 2002, Neuron.

[63]  Ruoyan Chen,et al.  Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain , 2003, Biological Psychiatry.

[64]  D. Chuang,et al.  Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: An essential step for neuroprotection against glutamate excitotoxicity , 2002, Neuropharmacology.

[65]  Guang Chen,et al.  In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3 , 2004, Neuropsychopharmacology.

[66]  M. Greenberg,et al.  Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis , 1995, Neuron.

[67]  J. Calabrese,et al.  Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. , 1994, JAMA.

[68]  H. Manji,et al.  Lithium Increases Tyrosine Hydroxylase Levels Both In Vivo and In Vitro , 1998, Journal of neurochemistry.

[69]  Guang Chen,et al.  Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? , 2000, Biological Psychiatry.

[70]  Y. Takiguchi,et al.  Effects of Lithium on the Pharmacokinetics of Valproate in Rats , 2000, The Journal of pharmacy and pharmacology.

[71]  H. Manji,et al.  Mood stabilizer psychopharmacology , 2002, Clinical Neuroscience Research.

[72]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[73]  Brian H. Peterson,et al.  Lithium and Valproate Decrease Inositol Mass and Increase Expression of the Yeast INO1 and INO2Genes for Inositol Biosynthesis* , 2001, The Journal of Biological Chemistry.

[74]  H. Manji,et al.  The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3 , 2000, Journal of neurochemistry.

[75]  C. Nemeroff,et al.  Effects of Sodium Valproate on Corticotropin-Releasing Factor Systems in Rat Brain , 2001, Neuropsychopharmacology.

[76]  C. Gross,et al.  Neurogenesis in the neocortex of adult primates. , 1999, Science.

[77]  H. Manji,et al.  The Mood Stabilizer Valproic Acid Activates Mitogen-activated Protein Kinases and Promotes Neurite Growth* , 2001, The Journal of Biological Chemistry.

[78]  J. Thome,et al.  cAMP Response Element-Mediated Gene Transcription Is Upregulated by Chronic Antidepressant Treatment , 2000, The Journal of Neuroscience.

[79]  Christina A. Wilson,et al.  GSK-3α regulates production of Alzheimer's disease amyloid-β peptides , 2003, Nature.

[80]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[81]  R. Jope,et al.  Mood stabilizers, glycogen synthase kinase-3β and cell survival , 2002, Molecular Psychiatry.

[82]  Andrew Lemire,et al.  Electroconvulsive Seizures Regulate Gene Expression of Distinct Neurotrophic Signaling Pathways , 2004, The Journal of Neuroscience.

[83]  A. Harwood,et al.  A common mechanism of action for three mood-stabilizing drugs , 2002, Nature.

[84]  S. Gabriel,et al.  Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. , 2002, Molecular psychiatry.

[85]  Y. Okamoto,et al.  Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain , 2001, Psychopharmacology.

[86]  M. Rizzo,et al.  The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade , 2002, FEBS letters.

[87]  T. Madsen,et al.  Chronic electroconvulsive seizure up-regulates β-catenin expression in rat hippocampus: role in adult neurogenesis , 2003, Biological Psychiatry.

[88]  G. Rajkowska,et al.  Enhancement of Hippocampal Neurogenesis by Lithium , 2000, Journal of neurochemistry.